Semler Scientific (SMLR)
(Delayed Data from NSDQ)
$26.11 USD
+0.20 (0.77%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $25.98 -0.13 (-0.50%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
SMLR 26.11 +0.20(0.77%)
Will SMLR be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for SMLR based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SMLR
After Plunging 30.3% in 4 Weeks, Here's Why the Trend Might Reverse for Semler Scientific Inc. (SMLR)
Semler Scientific Inc. (SMLR) Q3 Earnings Beat Estimates
SMLR: What are Zacks experts saying now?
Zacks Private Portfolio Services
Chemed (CHE) Roto-Rooter Business Grows, VITAS Admission Dips
Here's Why Investors Should Hold Exact Sciences (EXAS) Stock
Boston Scientific (BSX) Benefits From New Buyouts, FX Woes Stay
Other News for SMLR
The Healthcare Bargain Blitz: 7 Undervalued Stocks to Inject into Your Portfolio
Semler Scientific Inc (SMLR) Reports Robust Revenue and Net Income Growth in Q4 and Full Year 2023
Analysts’ Top Healthcare Picks: Semler Scientific (SMLR), Silk Road Medical (SILK)
SMLR Makes Notable Cross Below Critical Moving Average
12 Health Care Stocks Moving In Tuesday's Intraday Session